Sat Kartar Life Limited (NSE:SATKARTAR)

India · Delayed Price · Currency is INR

133.40

+0.65 (0.49%)

At close: Oct 16, 2026

Market Cap	2.10B -22.9%
Revenue (ttm)	2.01B +141.9%
Net Income	171.02M +582.4%
EPS	10.86 +385.4%
Shares Out	15.74M
PE Ratio	12.28
Forward PE	n/a
Dividend	0.70 (0.52%)
Ex-Dividend Date	Aug 21, 2026

Volume	124,800
Open	130.30
Previous Close	132.75
Day's Range	126.15 - 139.35
52-Week Range	110.30 - 219.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Sat Kartar Life

Sat Kartar Life Limited, an ayurvedic healthcare company, provides ayurvedic products in India. The company offers ayurvedic products, vitamins, supplements, and herbal products for various health conditions, including piles care, diabetes, sexual wellness, bones and joints, mind and lungs care, personal care, immune support, infertility support, PCO/PCOS, hair and liver care, addiction care, and respiratory support solutions. It sells its products through online platforms. The company was formerly known as Sat Kartar Shopping Limited and chang... [Read more]

Industry Pharmaceutical Preparations

Founded 2012

Employees 617

Stock Exchange National Stock Exchange of India

Ticker Symbol SATKARTAR

Full Company Profile

Financial Performance

In fiscal year 2026, Sat Kartar Life's revenue was 2.01 billion, an increase of 23.19% compared to the previous year's 1.63 billion. Earnings were 171.02 million, an increase of 74.24%.

Financial Statements